they recently bonused out $430k on top of small sa
Post# of 30028
but it comes with greater dilution and no REVENUE on the books
also, where is the below CEO 08/14 Blog milestone WRT the below bonus milestones
Quote:
"We project a partnership agreement for LymPro will follow shortly after the completion of the LP-002 study, and the Company is weighing strategic options which include a potential ‘spin-out’ of our diagnostics division (which includes LymPro and NuroPro)
http://www.thechairmansblog.com/amarantus-bio...XNxUH.dpuf
Quote:
Milestone: Nasdaq uplist
Bonus Performance: 30%
Completion Timing: 12/31/14
Milestone: Eltoprazine US IND filed and approved for LID
Bonus Performance: 30%
Completion Timing: 12/31/14
Milestone: LymPro partner validation of analytical performance package (APP) and CLIA certification
Bonus Performance: 25%
Completion Timing: 12/31/14
Milestone: MANF Orphan drug designation applications filed and approved for both Ocular Ischemic Syndrome (OIA) and Retinitis Pigmentosa
Bonus Performance: 15%
Completion Timing: 12/31/14